Citation Impact
Citing Papers
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
2006
The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
2009
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
2009
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
2009
HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
2009
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
2015
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Current knowledge on exosome biogenesis and release
2017 Standout
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
2014
Glutathione peroxidases
2012 Standout
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
2007
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
2008
The biology and management of non-small cell lung cancer
2018 StandoutNature
The MET receptor tyrosine kinase in invasion and metastasis
2007
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Lung Cancer
2008 Standout
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion
2007
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate
2010
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Understanding and targeting resistance mechanisms in NSCLC
2017
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
The molecular biology of head and neck cancer
2010 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer
2016
Antibody therapy of cancer
2012 Standout
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
C-MET as a new therapeutic target for the development of novel anticancer drugs
2010
From Tpr-Met to Met, tumorigenesis and tubes
2007
Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications
2006
The emerging role of MET/HGF inhibitors in oncology
2013
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
2011 Standout
Showering c-MET-dependent cancers with drugs
2008
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Tivantinib: A New Promising Mesenchymal–Epithelial Transition Factor Inhibitor in the Treatment of Hepatocellular Carcinoma
2013
Inhibition of the Met Receptor in Mesothelioma
2005
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
MET As a Possible Target for Non–Small-Cell Lung Cancer
2013
Targeting met mediated epithelial‐mesenchymal transition in the treatment of breast cancer
2014
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics
2007
Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
2005
Met degradation: more than one stone to shoot a receptor down
2012
Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
2013
Natural product and natural product derived drugs in clinical trials
2014 Standout
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
2011
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
2016
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras
2008
MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway
2016
Works of Simha Jagadeesh being referenced
Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer
2005
Small cell lung cancer: from molecular biology to novel therapeutics
2003
Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
2004